Cullinan therapeutics to host analyst and investor event at 2025 asco annual meeting and participate in jefferies 2025 global healthcare conference

Cambridge, mass., may 29, 2025 (globe newswire) -- cullinan therapeutics, inc. (nasdaq: cgem; “cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced its management team will host a company event at the 2025 american society of clinical oncology (asco) annual meeting in chicago, il and will participate in the jefferies 2025 global healthcare conference, being held june 3-5, 2025 in new york, ny.
CGEM Ratings Summary
CGEM Quant Ranking